文献速递肝病

慢加急性肝衰竭与失代偿期肝硬化患者的凝血衰竭:超越国际标准化比值

Coagulation Failure in Patients With Acute-on-Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio.
PubMed 文献 · Hepatology · 2018-11-09

该研究纳入慢加急性肝衰竭(ACLF)患者36例和急性失代偿(AD)患者24例,于入院时和72小时后行血栓弹力图检测。ACLF患者入院时凝血功能更偏低凝,72小时后进一步恶化,低凝状态与全身炎症相关并与28天和90天死亡率升高相关,但与输血需求和出血事件无关。

要点

  • ACLF患者入院时即表现为低凝特征,且72小时后血栓弹力图参数进一步恶化。
  • 低凝状态(3项及以上血栓弹力图参数超出范围)在ACLF患者中更常见,且与全身炎症相关。
  • 低凝状态与28天和90天死亡率升高相关,但与输血需求或出血事件无关。

核心结论

  • ACLF患者常表现为低凝特征,包括起始纤维蛋白形成时间延长、血凝块形成时间延长和血凝块强度降低;这些改变在入院后恶化,与全身炎症相关,并转化为更高的短期死亡率;低纤维蛋白溶解可能参与ACLF的器官衰竭。

研究设计与样本

  • 连续纳入ACLF患者36例和急性失代偿(AD)患者24例,于入院时和72小时后采集血样行血栓弹力图(TE)检测。
  • 评估有无ACLF及有无全身炎症反应综合征患者的凝血特征,并评估凝血特征对输血需求、出血事件和短期生存的影响。

主要发现

  • 入院时ACLF患者较AD患者表现出更多低凝特征,起始纤维蛋白形成时间和血凝块形成时间延长,最大血凝块强度和α角降低。
  • 72小时后ACLF患者TE参数恶化,而AD患者改善。
  • 低凝状态(3项及以上TE参数超出范围)的患病率在ACLF患者入院时显著高于AD患者(61% vs 29%;P=0.03),随访期间亦如此。
  • 低凝状态与全身炎症相关,并与更高的28天死亡率(45% vs 16%;P=0.02)和90天死亡率(52% vs 19%;P=0.01)相关,但与输血需求或出血无关。
  • 基线时起始纤维蛋白形成时间延长(外源性TE检测>80秒)和终末期肝病模型评分是28天死亡率的独立预测因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Balanced hemostasis with hypocoagulable and hypercoagulable features may occur in acute-on-chronic liver failure (ACLF). The characteristics and prognostic impact of the coagulation profile in ACLF are unknown. Consecutive patients with ACLF (n = 36) and acute decompensation (AD; n = 24) were included. Blood samples for thromboelastometry (TE) were obtained at admission and 72 hours thereafter. The coagulation profile was evaluated in patients with and without ACLF and in those with and without systemic inflammatory response syndrome. The impact of the coagulation profile on transfusion requirements, bleeding events, and short-term survival was assessed. At admission, patients with ACLF showed more hypocoagulable characteristics compared to AD subjects, with prolonged time to initial fibrin formation and clot formation time and decreased maximum clot firmness and alpha-angle values. TE parameters worsened at 72 hours in ACLF but improved in patients with AD. Prevalence of a hypocoagulable profile (three or more TE parameters outside range) was significantly higher in patients with ACLF either at admission (61% versus 29% in AD; P = 0.03) or during follow-up. Hypocoagulability correlated with systemic inflammation and was associated with higher 28-day (45% versus 16%; P = 0.02) and 90-day (52% versus 19%; P = 0.01) mortality rates but not with transfusion requirements or bleeding. Prolonged time to initial fibrin formation (extrinsic TE assay >80 seconds) and Model for End-Stage Liver Disease score at baseline were independent predictors of 28-day mortality. Conclusion: Patients with ACLF frequently show hypocoagulable features with prolonged time to initial fibrin formation and clot formation time and reduced clot firmness; these alterations worsen after admission, correlate with systemic inflammation, and translate into higher short-term mortality; hypofibrinolysis could contribute to organ failure in ACLF.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Blasi A, Calvo A, Prado V, et al. Coagulation Failure in Patients With Acute-on-Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio. Hepatology. 2018. PMID: 29790188. doi:10.1002/hep.30103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。